semaglutide
Wegovy Approved to Treat MASH With Moderate to Advanced Fibrosis
The FDA has approved semaglutide in conjunction with diet and exercise for the treatment of MASH with moderate to ...
AUGUST 20, 2025
How a GLP-1 ‘Shadow System’ Puts Patients’ Safety at Risk
Dozens of unscrupulous web-based sellers of glucagon-like peptide-1 agonist drugs are evading FDA scrutiny and ...
NOVEMBER 16, 2024
Study Finds GLP-1s Safe and Effective For Managing Obesity in Patients With IBD
GLP-1s are well tolerated and effective for weight loss in patients with IBD, according to new research
OCTOBER 31, 2024
Machine Learning Can Predict Best Responders to GLP-1s
Machine learning tools can sift through genetic profiles to predict which patients with obesity will best respond ...
SEPTEMBER 11, 2024
Expert Picks From DDW 2024, Part 1: IBD, EoE, NERD and More
In this installment of Expert Picks from DDW 2024, Anisa Shaker, MD, discusses five of her favorite abstracts and ...
JULY 12, 2024
Increased Constipation Risk Seen With Anti-Obesity Drugs, Particularly in Black Patients
The use of anti-obesity medications has increased in recent years, but few data exist on the effect of these ...
MAY 29, 2024
GLP-1RA Use Increases Gastric Food Retention Post-Endoscopy—But Fasting Mitigates This
Although patients appear more likely to retain stomach contents during endoscopic procedures, this risk may ...
MAY 19, 2024
Treating Patients With Inflammatory Bowel Disease and Obesity
An estimated 41% of the US population is obese, including 22% of individuals aged 12 to 19 years, while nearly 1 of ...
MAY 10, 2024
ASHP Reports Drug Shortages Hit a 2-Decade High
The number of active, ongoing drug shortages has reached 323, the highest tally the American Society of ...
APRIL 25, 2024
FDA Warns About Counterfeit Ozempic Found in U.S. Drug Supply Chain
The FDA reported counterfeit semaglutide was found in the legitimate U.S. drug supply chain and has seized ...
JANUARY 16, 2024
Advances Usher In Era of Personalized Treatment for Obesity
The multifaceted, complex medical problem that is obesity is seeing big advances that are starting to have a major ...
JANUARY 15, 2024
The Incretin Effect
What is the effect of glucagon-like peptide-1 agonists, "the holy grail" for the obesity epidemic, on anesthesia?
DECEMBER 27, 2023
